bioRxivBiochemistry
Biological evaluation of novel side chain containing CQTrICh-analogs as antimalarials and their development as PfCDPK1 kinase inhibitors
I. Irfan, A. Uddin, R. Jain, A. Gupta, S. Gupta, J. V. Napoleon, A. Hussain, M. F. Alajmi, M. C. Joshi, P. Hasan, M. Abid, S. Singh
Abstract
To combat the emergence of drug resistance against the existing antimalarials, novel side chain containing 7-chloroquinoline-indole-chalcones tethered with a triazole (CQTrICh-analogs 7 (a-s) and 9) were designed and synthesized by reacting substituted 1-phenyl-3-(1-(prop-2-yn-1- yl)-1H-indol-3-yl) prop-2-en-1-one and 1-(prop-2-yn-1-yl)-1H-indole-3-carbaldehyde with 4- azido-7-chloroquinoline, respectively via a click reaction. The selected CQTrICh-analogs: 7l and 7r inhibited chloroquine-sensitive (3D7) and resistant (RKL-9) strains of Plasmodium falciparum, with IC50 values of 2.4 {micro}M & 1.8 {micro}M (7l), and 3.5 {micro}M & 2.7 {micro}M (7r), respectively, and showed insignificant hemolysis and cytotoxicity in mammalian cells. Intra-erythrocytic progression studies revealed that the active hybrids: 7l and 7r are effective against the mature stages of the parasite. Given the importance of Calcium-Dependent Protein Kinase 1 (PfCDPK1) in the parasite biology, notably during late schizogony and subsequent invasion of merozoites into host RBCs, we identified this protein as a possible molecular target of these active hybrids. In silico interaction analysis indicated that 7l and 7r stably interact with the catalytically active ATP-binding pocket of PfCDPK1, by the formation of energetically favorable H-bonds. Furthermore, in vitro Microscale Thermophoresis and kinase assays with recombinant PfCDPK1 demonstrated that the active hybrids interact with and inhibit the kinase activity, thus presumably responsible for the parasite growth inhibition. Interestingly, 7l and 7r showed no inhibitory effect on the human kinases, indicating that they are selective for the parasite kinase. Conceivably, we report the antiplasmodial potential of novel kinase targeting bio-conjugates, a step towards developing pan-kinase inhibitors, which is a prerequisite for cross-stage anti-malarial protection. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=115 SRC="FIGDIR/small/498981v1_ufig1.gif" ALT="Figure 1"> View larger version (22K): org.highwire.dtl.DTLVardef@113574borg.highwire.dtl.DTLVardef@c81a33org.highwire.dtl.DTLVardef@1301d22org.highwire.dtl.DTLVardef@1c8cac5_HPS_FORMAT_FIGEXP M_FIG C_FIG
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Development of novel anti-malarial from structurally diverse library of molecules, targeting plant-like Calcium Dependent Protein Kinase 1, a multistage growth regulator of P. falciparum
- Targeting Plasmodium falciparum calcium dependent protein kinase-1: Computational modelling approach towards the discovery of antimalarial drug from medicinal herbs and clinically approved anti-malarial drugs pharmacophores
Temitope Isaac Adelusi, Taiwo Ooreoluwa Ojo, … Elijah Kolawole Oladipo·bioRxiv·Aug 22, 2022
- Drug repurposing approach for potential Pfmrk inhibitors as antimalarial agents: an In-silico analysis
- Discovery of novel potent, cell-permeable inhibitors of P. falciparum cGMP-dependent protein kinase.
R. R. Y. Bheemanaboina, M. L. Gonzalez, … D. Rotella·bioRxiv·Aug 24, 2021
- Discovery of imidazole-based inhibitors of P. falciparum cGMP-dependent protein kinase
R. R. Yadav, M. L. de Souza, … D. P. Rotella·bioRxiv·Nov 5, 2021
- The Human Chk1 Inhibitor CHIR-124 Shows Multistage Activity Against the Human Malaria Parasite Plasmodium falciparum via Polypharmacological Inhibition of PfArk1 and Hemozoin Formation
Kathryn J. Wicht, John G. Woodland, … Kelly Chibale·ACS Chemical BiologyPeer-reviewed·Jun 13, 2026